1. Break through the bottleneck of generic drug technology, reduce the production cost by more than 10% and increase the yield by 5-10%;
2. Launch 1-2 generic drugs with high added value and complete FDA system certification;
3. Increased the market share of the company's contrast agent products in European and American countries by 20%.

Expert qualification required:

1. Have more than 10 years' experience in r&d team management, and priority will be given to r&d leaders or chief scientists of companies like Mallinckrodt, Bracco, GE, Bayer, Guerbet, Pfizer, Roche, Novartis，MSD，Sanofi;
2. Preference will be given to personnel with related working background in chemical generic drugs, who can understand Chinese;
3. Able to adapt to work and life in China, working in China for more than 9 months every year.